The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Korkmaz, B.
Right arrow Articles by Gauthier, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Korkmaz, B.
Right arrow Articles by Gauthier, F.
The Journal of Immunology, 2005, 175: 3329-3338.
Copyright © 2005 by The American Association of Immunologists

Inhibition of Neutrophil Elastase by {alpha}1-Protease Inhibitor at the Surface of Human Polymorphonuclear Neutrophils1

Brice Korkmaz*, Sylvie Attucci*, Marie-Lise Jourdan{dagger}, Luiz Juliano{ddagger} and Francis Gauthier2,*

* University François Rabelais, Institut National de la Santé et de la Recherche Médicale Unité 618 Protéases et Vectorisation Pulmonaires, and Institut Fédératif de Recherche 135 Imagerie Fonctionnelle; {dagger} Institut National de la Santé et de la Recherche Médicale Equipé 211 Nutrition et Cancer, Tours, France; and {ddagger} Universidade Federal, Departamento de Biofísica, Escola Paulista de Medicina, São Paulo, Brazil

The uncontrolled proteolytic activity in lung secretions during lung inflammatory diseases might be due to the resistance of membrane-bound proteases to inhibition. We have used a new fluorogenic neutrophil elastase substrate to measure the activity of free and membrane-bound human neutrophil elastase (HNE) in the presence of {alpha}1-protease inhibitor ({alpha}1-Pi), the main physiological inhibitor of neutrophil serine proteases in lung secretions. Fixed and unfixed neutrophils bore the same amounts of active HNE at their surface. However, the HNE bound to the surface of unfixed neutrophils was fully inhibited by stoichiometric amounts of {alpha}1-Pi, unlike that of fixed neutrophils. The rate of inhibition of HNE bound to the surface of unfixed neutrophils was the same as that of free HNE. In the presence of {alpha}1-Pi, membrane-bound elastase is almost entirely removed from the unfixed neutrophil membrane to form soluble irreversible complexes. This was confirmed by flow cytometry using an anti-HNE mAb. HNE activity rapidly reappeared at the surface of HNE-depleted cells when they were triggered with the calcium ionophore A23187, and this activity was fully inhibited by stoichiometric amounts of {alpha}1-Pi. HNE was not released from the cell surface by oxidized, inactive {alpha}1-Pi, showing that active inhibitor is required to interact with active protease from the cell surface. We conclude that HNE activity at the surface of human neutrophils is fully controlled by {alpha}1-Pi when the cells are in suspension. Pericellular proteolysis could be limited to zones of contact between neutrophils and subjacent protease substrates where natural inhibitors cannot penetrate.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
B. Korkmaz, J. Jaillet, M.-L. Jourdan, A. Gauthier, F. Gauthier, and S. Attucci
Catalytic Activity and Inhibition of Wegener Antigen Proteinase 3 on the Cell Surface of Human Polymorphonuclear Neutrophils
J. Biol. Chem., July 24, 2009; 284(30): 19896 - 19902.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Korkmaz, A. Kuhl, B. Bayat, S. Santoso, and D. E. Jenne
A Hydrophobic Patch on Proteinase 3, the Target of Autoantibodies in Wegener Granulomatosis, Mediates Membrane Binding via NB1 Receptors
J. Biol. Chem., December 19, 2008; 283(51): 35976 - 35982.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Attucci, A. Gauthier, B. Korkmaz, P. Delepine, M. F.-D. Martino, F. Saudubray, P. Diot, and F. Gauthier
EPI-hNE4, a Proteolysis-Resistant Inhibitor of Human Neutrophil Elastase and Potential Anti-Inflammatory Drug for Treating Cystic Fibrosis
J. Pharmacol. Exp. Ther., August 1, 2006; 318(2): 803 - 809.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.